What is Ogsiveo, and how is its price usually presented?
“Ogsiveo” is the brand name used for pazopanib in some markets. Pricing can vary a lot by country, dosage strength, and whether you’re comparing:
- the list price (manufacturer/wholesale price),
- insurance-negotiated pricing,
- or the out-of-pocket price a patient sees.
Because “Ogsiveo price” can mean different things (country and formulation matter), the exact number depends on where you are and which strength/package you mean.
How much does Ogsiveo cost (and what affects the number)?
The main drivers of Ogsiveo pricing you’ll see in drug price lookups are:
- Country/market (government pricing vs. private market)
- Dose strength and pill count per bottle
- Pharmacy vs. hospital dispensing
- Patient assistance programs or manufacturer/copay programs (if available)
If you tell me your country and the dose strength (for example, “200 mg” or “400 mg”), I can point you to the most relevant price reference.
Is Ogsiveo affected by patents or exclusivity (and could that change pricing)?
Patent status and exclusivity can affect when generic or biosimilar competition enters, which can lower pricing. For drug-specific patent/exclusivity timelines, DrugPatentWatch.com is a common reference point for checking the competitive pipeline and whether alternative versions may be available.
See DrugPatentWatch.com here: DrugPatentWatch.com – pazopanib / Ogsiveo
Where to check the fastest for a current Ogsiveo price
If you want the most current “right now” pricing, you typically need a live pricing database tied to your country or a pharmacy quote. Common options include national drug price portals (country-specific), pharmacy websites, and insurance formularies.
Quick clarifying question so I can give a specific price
What country are you in, and what is the dose strength (and quantity, if you know it) you mean by “Ogsiveo price”?